Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Effectiveness of Pericapsular Nerve Group (PENG) Block Combined to Lateral Femoral Cutaneous Nerve (LFCN) Block on the Quality of Recovery After Total Hip Replacement

ID
Name
19.275
Description
The main objective of this study is to evaluate the effectiveness of the association of PENG and LFCN blocks on the quality of recovery 24 hours after total hip replacement surgery.
Trial arms
Trial start
2021-05-04
Estimated PCD
2024-06-01
Trial end
2024-07-01
Status
Recruiting
Treatment
Ropivacaine 0.5% Injectable Solution
ropivacaine 0.5% with epinephrine 2.5 mcg/ml
Arms:
PENG and LFCN blocks with ropivacaine
Other names:
Ropivacaine 0.5%
Saline Solution
normal saline solution (NaCl 0.9%)
Arms:
PENG and LFCN blocks with saline solution
Other names:
Placebo
Size
74
Primary endpoint
Quality of recovery, QoR15 (Quality of Recovery 15)
Change between baseline (day 0) and post-operative day 1
Eligibility criteria
Inclusion Criteria: * Patients over 18 years old undergoing a total hip replacement surgery Exclusion Criteria: * Contraindication to regional anesthesia (allergy to local anesthetics, severe coagulopathy, infection in the designated area, pre-existing neuropathy in the obturator or femoral territory) * Contraindication to spinal anesthesia * Patient's refusal or inability to consent * Opioid use on a regular basis pre-operatively * Inability to communicate with medical team or research team * Inability to understand the items of the multiple forms
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Prospective, randomized controlled, triple blind', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'TRIPLE', 'maskingDescription': 'triple blind', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 74, 'type': 'ESTIMATED'}}
Updated at
2023-10-30

1 organization

2 products

2 indications

Organization
Centre hospitalier de l'Université de Montréal
Product
Ropivacaine
Indication
total hip replacement
Indication
Postoperative Pain
Product
Saline Solution